MedPath
NMPA Approval

Levosalbutamol Hydrochloride Nebuliser Solution

国药准字H20234384

March 6, 2024

Drug Information

盐酸左沙丁胺醇雾化吸入溶液

吸入制剂

按C₁₃H₂₁NO₃计 3ml:0.63mg

化学药品

March 6, 2024

Company Information

Applicant Company

湖南浏阳生物医药园区

Manufacturing Company

湖南浏阳生物医药园区;浏阳经济技术开发区健康大道南路5号

© Copyright 2025. All Rights Reserved by MedPath